Mineralys Therapeutics (MLYS) Non Operating Income (2022 - 2026)

Quarterly results put Non Operating Income at $6.0 million for Q1 2026, up 168.38% from a year ago — trailing twelve months through Mar 2026 was $13.7 million (up 353.81% YoY), and the annual figure for FY2024 was $5000.0, down 99.96%.

Mineralys Therapeutics has reported Non Operating Income over the past 5 years, most recently at $6.0 million for Q1 2026.

  • Non Operating Income reached $6.0 million in Q1 2026 per MLYS's latest filing, up from $1000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $6.0 million in Q1 2026 and bottomed at -$11.8 million in Q4 2024.
  • Median Non Operating Income over the past 5 years was $2.8 million (2023), compared with a mean of $1.6 million.
  • The largest annual shift saw Non Operating Income plummeted 454.21% in 2024 before it surged 42090.0% in 2025.
  • Over 5 years, Non Operating Income stood at $935000.0 in 2022, then skyrocketed by 255.29% to $3.3 million in 2023, then tumbled by 454.21% to -$11.8 million in 2024, then soared by 100.01% to $1000.0 in 2025, then surged by 600000.0% to $6.0 million in 2026.
  • Business Quant data shows Non Operating Income for MLYS at $6.0 million in Q1 2026, $1000.0 in Q4 2025, and $4.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 444,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 201.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -46.98 Mn
10 Mineralys Therapeutics 2.50 Bn 2.50 Bn - 6.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.00 Mn
Dec 31, 2025 1,000.00
Sep 30, 2025 4.20 Mn
Jun 30, 2025 3.47 Mn
Mar 31, 2025 2.24 Mn
Dec 31, 2024 -11.77 Mn
Sep 30, 2024 -10,000.00
Jun 30, 2024 4.15 Mn
Mar 31, 2024 3.85 Mn
Dec 31, 2023 3.32 Mn
Jun 30, 2023 3.59 Mn
Mar 31, 2023 2.33 Mn
Dec 31, 2022 935,000.00
Sep 30, 2022 745,000.00